SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-19-011221
Filing Date
2019-11-27
Accepted
2019-11-26 19:58:33
Documents
8
Period of Report
2020-01-21
Effectiveness Date
2019-11-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A def14a.htm DEF 14A 971668
3 GRAPHIC correspg001.jpg GRAPHIC 1768
4 GRAPHIC def14ag001.jpg GRAPHIC 88851
5 GRAPHIC def14ag002.jpg GRAPHIC 4250
6 GRAPHIC def14ag003.gif GRAPHIC 117466
7 GRAPHIC def14ag004.gif GRAPHIC 84879
8 GRAPHIC def14ag005.gif GRAPHIC 109505
9 GRAPHIC def14ag006.gif GRAPHIC 105877
  Complete submission text file 0001558370-19-011221.txt   1679637
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37350 | Film No.: 191252768
SIC: 3841 Surgical & Medical Instruments & Apparatus